Bortezomib to Treat Significant Complication of HSCT

Clinical trial NCT01929980 · COMPLETED

Trial details

NCT number: NCT01929980
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allogeneic Stem Cell Transplantation Refractory Autoimmune Cytopenia(s)

Start date: 2012-07-01
Primary completion: 2014-05-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.